Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Net Income | -1.17M | -835.80K | -716.60K | -3.86M | -1.30M |
| Total Depreciation and Amortization | 113.80K | 114.60K | 115.30K | 116.60K | 117.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 201.30K | 343.20K | 43.40K | 2.87M | 151.80K |
| Change in Net Operating Assets | 741.60K | 177.80K | 272.80K | 558.90K | 364.20K |
| Cash from Operations | -110.30K | -200.30K | -285.10K | -315.20K | -669.70K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -1.50K | -1.60K |
| Sale of Property, Plant, and Equipment | -- | -3.20K | 0.00 | 3.20K | -6.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.00 | 0.00 | 0.00 | 50.40K | 0.00 |
| Cash from Investing | -300.00 | -3.20K | 0.00 | 52.10K | -8.20K |
| Total Debt Issued | 157.60K | 241.00K | 274.50K | 237.80K | 637.30K |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 157.60K | 241.00K | 274.50K | 237.80K | 637.30K |
| Foreign Exchange rate Adjustments | -43.70K | -37.90K | 5.30K | -7.90K | -30.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.30K | -300.00 | -5.30K | -33.30K | -71.20K |